Skip to content

Clinical trials

Completed Carcinoma, Hepatocellular trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Completed Country / region: Japan Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20072
20082
20096
20104
20113
20123
20137
20143
20155
20161
20176
20184
20196
20201
20215
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer11
Bristol-Myers Squibb7
Eisai Co., Ltd.5
Novartis Pharmaceuticals4
Pfizer4
AstraZeneca3
Eli Lilly and Company3
Hoffmann-La Roche3
Merck Sharp & Dohme LLC3
AbbVie2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular62
Liver Neoplasms12
Neoplasms9
Carcinoma5
Carcinoma, Non-Small-Cell Lung4
Stomach Neoplasms4
Carcinoma, Merkel Cell3
Cholangiocarcinoma3
Melanoma3
Mesothelioma3

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.